Pharmacyclics

Acquired
Employees
201–500
Business Model
B2B

About

Biopharmaceutical company focused on cancer and immune-mediated disease therapies, acquired by AbbVie in 2015.

Summary

Pharmacyclics is a Biotech company based in Sunnyvale, United States. Investors include AbbVie Ventures and Venrock.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionMar 2015
$21.0B

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies